Physician profile
Jonathan B Geach
NPI 1881871283
$3,349.31
in general payments reported to CMS, 2019-2025
18 companies · $538 in 2025
The $538 reported for 2025 was more than what 91% of Anesthesiology providers received nationally (typical 2025 total: $58.09).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $246 · 2021: $16.14 · 2022: $235 · 2023: $1,960 · 2024: $354 · 2025: $538.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,458 · Travel and Lodging: $1,393.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,458.19 |
| Travel and Lodging | $1,393.15 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $1,736.70 | 2023-2025 | Wavewriter Alpha Prime 16 |
| Medtronic, INC. | $409.48 | 2022-2024 | Intellis Adaptivestim |
| Biotronik Nro, INC. | $147.51 | 2025 | Prospera |
| Abbott Laboratories | $138.44 | 2022-2025 | Eterna |
| Vertos Medical, INC. | $137.19 | 2023-2024 | Mild Device Kit |
| Avanos Medical | $132.16 | 2020 | |
| Edwards Lifesciences Corporation | $114.23 | 2020 | |
| Painteq LLC | $88.94 | 2022-2024 | Painteq |
| Nevro Corp. | $77.20 | 2023-2024 | Senza |
| Abbvie INC. | $67.54 | 2023-2024 | |
| Nalu Medical, INC. | $61.13 | 2023-2024 | Nalu Neurostimulation System |
| Spr Therapeutics, INC | $56.00 | 2022 | |
| Si-Bone, INC. | $55.03 | 2025 | |
| Saluda Medical Americas, INC. | $36.74 | 2025 | Evoke |
| Globus Medical, INC. | $33.64 | 2025 | Senza |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Heron Therapeutics, INC. | $23.31 | 2025 | Zynrelef |
| Pacira Pharmaceuticals Incorporated | $17.93 | 2025 | Exparel |
| Scilex Pharmaceuticals INC. | $16.14 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jonathan Geach listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.